Proposed Update on Substaging Metastatic Prostate Cancer

Urology

Volumn 74, Issue 1, 2009, Pages 237-

  Crawford, E David ^a   Connor, Timothy ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Dendreon Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ANDROGEN DEPRIVATION THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; DRUG APPROVAL; GESTALT THERAPY; LETTER; METASTASIS; PATIENT IDENTIFICATION; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT FAILURE; UNITED STATES;

HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TREATMENT FAILURE;

EID: 67649211458     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.03.005     Document Type: Letter

References (1)

1. Crawford E.D., and Blumenstein B. Proposed substages for metastatic prostate cancer. Urology 50 (1997) 1027-1028